Citations

Showing 10 of 108094 citations.

Standardizing Second-Trimester Medical Termination: Effects on Clinical Outcomes
Wyatt, Michelle A. , Tolcher, Mary Catherine

Mayo Clinic

American Journal of Perinatology | January 5, 2018 | Volume: 35 | Issue: 08 | Pages: 791-795

10.1055/s-0037-1619449 | PMID 29304543 Get It

Objective The objective of this study was to evaluate length of induction and postdelivery complications before and after implementation of a standardized approach to second-trimester medical termination of pregnancy. Study Design This was a retrospective cohort study of all women undergoing medical termination of pregnancy between 130/7 and 266/7 weeks of gestation at a single, academic institution from July 1, 2012, through June 30, 2015. The primary outcome was the time from the start of induction of labor to delivery of the fetus. Postdelivery complications including the need for dilation and curettage (D&C), blood transfusion, and readmission to the hospital were secondary outcomes of interest. Results A total of 62 women met inclusion criteria; 38 before and 24 after the intervention. There were no differences in measured baseline characteristics (p > 0.05). There was a significant decrease in induction time after the intervention (12.3 compared with 8.6 hours, p = 0.031). There was no significant difference in rates of D&C or other measured complications (p > 0.05). Conclusion Implementation of a standardized clinical guideline for second-trimester medical termination was associated with a decrease in length of induction. There was no significant difference in need for D&C or postdelivery complications; however, we were underpowered for these secondary outcomes.
Response to Joshi and Langley-Degroot
Hughes, A.J. , Singh, Balwinder

Mayo Clinic

American Journal of Psychiatry Residents' Journal | January 5, 2018 | Volume: 13 | Issue: 1 | Pages: 9-10

10.1176/appi.ajp-rj.2018.130105 Get It

Direct-from-Blood-Culture Disk Diffusion To Determine Antimicrobial Susceptibility of Gram-Negative Bacteria: Preliminary Report from the Clinical and Laboratory Standards Institute Methods Development and Standardization Working Group
Chandrasekaran, Sukantha , Campeau, Shelley, Zimmer, Barbara L., Weinstein, Melvin P., Thrupp, Lauri, Hejna, John, Walker, Lindsey, Ammann, Tracy, Kirn, Thomas, Patel, Robin , Humphries, Romney M. , Patel, Robin , Humphries, Romney , Abbott, April N. , Zimmer, Barbara L., Walker, Lindsey, Kirn, Thomas

Mayo Clinic

Journal of Clinical Microbiology | January 5, 2018 | Volume: 56 | Issue: 3 | Pages: No page available

10.1128/jcm.01678-17 | PMID 29305540 Get It

ABSTRACT The performance of a disk diffusion test using broth from positive blood cultures as inoculum (direct disk diffusion [dDD]) was evaluated for a collection of 20 challenge isolates of Enterobacteriaceae , Acinetobacter baumannii , and Pseudomonas aeruginosa . Isolates seeded into human blood were inoculated into Bactec Plus Aerobic/F, VersaTREK Redox 1, and BacT/Alert FA Plus bottles and incubated in the respective automated blood culture systems. Disk diffusion results were compared to reference disk diffusion results. Categorical agreement (CA) values for dDD, after removal of random errors due to natural MIC variation, were 87.8%, 88.4%, and 92.2% for the BacT/Alert, Bactec, and VersaTREK systems, respectively. No very major errors (VME) were observed, and major error (ME) rates were 3.0%, 2.3%, and 1.7%, respectively. Incubation of the dDD test samples for 6 h compared to incubation for 16 to 18 h resulted in 19.9% of tests having too light of growth to allow reading of zones of inhibition. Among the evaluable dDD tests, CA values were 58.9%, 76.6%, and 73.2% for the isolates seeded into the BacT/Alert, Bactec, and VersaTREK systems, respectively. VME rates for isolates seeded into these systems were 2.2%, 1.8%, and 3.0%, respectively, and ME rates were 25.4%, 6.1%, and 2.8%, respectively, at the 6-h reading. The best performance of dDD was found for blood cultures with bacterial concentrations in the range of 7.6 × 10 7 to 5.0 × 10 8 CFU/ml; CA values ranged from 94.7 to 96.2% for these concentrations after 18 h of incubation and from 76.9 to 84.1% after 6 h of incubation. These preliminary data demonstrate the potential accuracy of dDD testing by the clinical laboratory.
Hydrogel Nanosensors for Colorimetric Detection and Dosimetry in Proton Beam Radiotherapy
Inamdar, Sahil , Pushpavanam, Karthik , Lentz, Jarrod M. , Bues, Martin , Anand, Aman, Anand, Aman Raj , Rege, Kaushal

Mayo Clinic

ACS Applied Materials & Interfaces | January 5, 2018 | Volume: 10 | Issue: 4 | Pages: 3274-3281

10.1021/acsami.7b15127 | PMID 29303547 Get It

Mutational Alterations of the p16CDKN2A Tumor Suppressor Gene Have Low Incidence in Mesenchymal Chondrosarcoma
Bae, Dae Kyung , Yk, Park, Chi, S.-G., Unni, K. Krishnan, Lee, C.W.

Mayo Clinic

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics | January 5, 2018 | Volume: 12 | Issue: 1 | Pages: 5-10

10.3727/000000001108747381 | PMID 11061340 Get It

Relevance of the Updated Food and Drug Administration Alteplase Label for Acute Ischemic Stroke: The Estimated Impact and Current Guidelines
Shiue, Harn , Albright, Karen C. , Sands, Kara, Shiue, Harn J, Sands, Kara A, Shiue, Harn J

Mayo Clinic

Annals of Pharmacotherapy | January 5, 2018 | Volume: 52 | Issue: 4 | Pages: 388-391

10.1177/1060028017751175 | PMID 29302990 Get It

In 2015, the Food and Drug Administration updated the contraindications for the use of alteplase in acute ischemic stroke (AIS), potentially creating a greater impact on treatment. A history of intracranial hemorrhage and recent stroke within 3 months were removed as contraindications, increasing the number of patients eligible for alteplase. The aim of this commentary is to call attention to the updates and discuss them relative to current American Heart Association/American Stroke Association guidelines. Additionally, we estimate the clinical impact of the updates by analyzing AIS admissions to a large-volume Comprehensive Stroke Center.
First report of proton beam therapy for breast angiosarcoma from the prospective PCG registry
Thorpe, C.S. , Brunnhoelzl, Daniel , McGee, L.A. , Kesslering, Christy, Hartsell, William F. , Vargas, Carlos , Thorpe, Cameron S, Niska, Joshua R, McGee, Lisa A, Thorpe, Cameron S , Niska, Joshua R.

Mayo Clinic

Acta Oncologica | January 5, 2018 | Volume: 57 | Issue: 7 | Pages: 992-994

10.1080/0284186x.2017.1423179 | PMID 29303019 Get It

What is the fate of artificial urinary sphincters among men undergoing repetitive bladder cancer treatment?
Heiner, S. Mitchell, Viers, Boyd R. , Rivera, Marcelino , Linder, Brian J. , Elliott, Daniel S. , Rivera, Marcelino E, Linder, Brian J , Viers, Boyd R

Mayo Clinic

Investigative and Clinical Urology | January 5, 2018 | Volume: 59 | Issue: 1 | Pages: 44

10.4111/icu.2018.59.1.44 | PMID 29333514 Get It

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
Calkins, Hugh , Hindricks, Gerhard , Cappato, Riccardo , Kim, Young‐Hoon , Aguinaga, Luis, Akar, Joseph G. , Badhwar, Vinay , Camm, A. John , Chen, Peng‐Sheng , Chen, Shih‐Ann , Chung, Mina K. , Nielsen, Jens Cosedis , Curtis, Anne B. , Davies, D. Wyn, Groot, Natasja M.S. de , Duytschaever, Mattias , Edgerton, James R. , Ellenbogen, Kenneth A. , Ernst, Sabine , Fenelon, Guilherme , Gerstenfeld, Edward P. , Haines, David E. , Haïssaguerre, Michel , Jackman, Warren M. , Jalife, José , Kalman, Jonathan M. , Kautzner, Josef , Kottkamp, Hans , Kuck, Karl Heinz, Kumagai, Koichiro , Lee, Richard, Lewalter, Thorsten , Lindsay, Bruce D., Mansour, Moussa , Michaud, Gregory F., Nakagawa, Hiroshi , Natale, Andrea , Okumura, Ken , Packer, Douglas L. , Reynolds, Matthew R. , Sanders, Prashanthan , Scanavacca, Maurício , Schilling, Richard J. , Tondo, Claudio , Tsao, Hsuan-Ming, Verma, Atul , Wilber, David J. , Haı̈ssaguerre, Michel , Packer, Douglas, Verma, Atul , Natale, Andrea , Sanders, Prashanthan , Nielsen, Jens C , de Groot, Natasja M S , Saad, Eduardo , Brugada, Josép , Day, John , d'Avila, Andre , Biase, Luigi Di , Ellinor, Patrick T. , Haissaguerre, Michel , Helm, Robert H. , Hylek, Elaine M. , Macle, Laurent , Marchlinski, Francis E. , Michaud, Gregory F. , Nattel, Stanley , Pokushalov, Evgeny A. , Tsao, Hsuan-Ming, Yamane, Teiichi , Scanavacca, Maurício , Tondo, Claudio , Ernst, Sabine , Ellenbogen, Kenneth A

Mayo Clinic

EP Europace | January 5, 2018 | Volume: 20 | Issue: 1 | Pages: 157-208

10.1093/europace/eux275 | PMID 29016841 Get It

The acute effects of a multi-ingredient pre-workout supplement on resting energy expenditure and exercise performance in recreationally active females
Camic, Clayton L., Doberstein, Scott, Erickson, Jacob L. , Jagim, Andrew R. , Jagim, Andrew R , Cameron, Michael

Mayo Clinic

Journal of the International Society of Sports Nutrition | January 5, 2018 | Volume: 15 | Issue: 1 | Pages: No page available

10.1186/s12970-017-0206-7 | PMID 29311763 Get It